Skip to main content
Clinical Trials/NCT01369940
NCT01369940
Completed
Not Applicable

NICHD Fetal Growth Study: Twin Gestations

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)9 sites in 1 country171 target enrollmentMay 29, 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fetal Growth Restriction
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Enrollment
171
Locations
9
Primary Endpoint
Fetal growth trajectories in dichorionic twin pregnancies
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Normal growth and development of twins are important for the long-term health of the children. The purpose of this study was to empirically define the trajectory of fetal growth in dichorionic twins using longitudinal two-dimensional ultrasonography and to compare the fetal growth trajectories for dichorionic twins with those based on a growth standard developed by our group for singletons. This knowledge may lead to interventions that could minimize or prevent pregnancy and newborn health problems in the future.

Detailed Description

A prospective cohort of 171 women with twin gestations was recruited from eight U.S. sites from 2012 to 2013. After an initial sonogram at 11w0d-13w6d where dichorionicity was confirmed, women were randomized to one of two serial ultrasonology schedules. Ultrasound measurements at each follow-up visit included standard fetal biometrics ((BPD, HC, AC, FL); estimated fetal weight was calculated using a Hadlock formula. Growth curves and percentiles were estimated using linear mixed models with cubic splines. Percentiles were compared statistically at each gestational week between the twins and 1,731 singletons in the Fetal Growth Studies-Singletons cohort. In addition to 2-D ultrasound measures for analyzing fetal growth, this study recorded maternal anthropometrics and a brief interview to capture changes in health status, stress and depression, and physical activity at each follow-up visit. Four blood draws at baseline and at targeted gestational ages for the eventual identification of biomarkers indicative of fetal growth were collected. After delivery, neonatal anthropometric measures were assessed for each twin, placental biospecimens were collected, and select information about the obstetrical course and newborn status were abstracted from medical charts. These exposures and outcomes provide opportunities to further compare singleton and twin gestations with respect to maternal biomarkers of fetal growth, well-being and maternal nutritional status using banked biospecimens to determine if the biomarkers ranges established for singletons are applicable to twin gestations. Biospecimen Description: * Maternal blood sample (serum, plasma, white blood cells, red blood cells and PAXgene RNA) at enrollment, 1st, 3rd, 5th follow-up visits, and delivery * Cord blood and placentas for consenting women collected at delivery * Placenta sample or buccal swab (determining zygosity by DNA probe for same sex pairs), collected at delivery

Registry
clinicaltrials.gov
Start Date
May 29, 2011
End Date
September 30, 2014
Last Updated
8 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Fetal growth trajectories in dichorionic twin pregnancies

Time Frame: 3 years

Fetal growth trajectories in dichorionic twin pregnancies were created using two- and selected three-dimensional ultrasound measures. Measures included maternal anthropometric measurements and 2D fetal biometry (BPD, HC, AC, FL) using standardized protocols. Women were recruited during the first trimester and followed until delivery. Each woman had seven scheduled ultrasound examinations, one at enrollment and six during follow-up visits. Women were randomized to receive sonograms according to one of the following two schedules: schedule A: 16, 20, 24, 28, 32 and 35 weeks or schedule B: 18, 22, 26, 30, 34 and 36 weeks.

Comparison of the fetal growth trajectories for dichorionic twins with singletons

Time Frame: 3 years

The primary analysis compared fetal growth trajectories for dichorionic twins with 1,737 singleton gestations included in the NICHD Fetal Growth Studies - Singleton standard. For modeling twin trajectories, we used linear mixed models with a cubic spline mean structure and a random effects structure that included linear, quadratic, and cubic random effects for the twin pair and an intercept term for the individual fetus within twin pair. The linear mixed models were also used to test for overall differences (i.e., global tests) between the twin and singleton trajectories (for EFW and other measurements) using likelihood ratio tests of interaction terms between spline mean structure terms and twin-singleton indicator variables.

Incidence of fetal growth restriction (with small-for-gestational age as a proxy) in dichorionic twins (by zygosity)

Time Frame: 3 years

Using small-for-gestational age as a proxy for growth restriction, we evaluated the percentage of dichorionic twins who would be classified below the 10th percentile using the study-generated singleton non-Hispanic white standard.

Comparison of singleton and twin gestations for maternal biomarkers of fetal growth

Time Frame: 3 years

Longitudinal data will compare singleton and twin gestations with respect to maternal biomarkers of fetal growth, well-being and maternal nutritional status using banked biospecimens to determine if the biomarkers ranges established for singletons are applicable to twin gestations.

Secondary Outcomes

  • Body composition(3 years)
  • Genetic and environmental factors affecting fetal growth(3 years)
  • Biospecimen repository(3 years)
  • Conception mode and growth trajectories(3 years)
  • Zygosity and growth trajectories(3 years)
  • Placental pathology and growth trajectories(3 years)

Study Sites (9)

Loading locations...

Similar Trials